About ConcePTION

ConcePTION is a project funded by the Innovative Medicines Initiative, a private public partnership. The project was launched in April 2019.

We believe that we have an important societal obligation to radically and rapidly reduce uncertainty about the effects of medication used during pregnancy and breastfeeding to benefit women in making informed decisions about medications used before, during and after pregnancy.

Reporting medicine use in pregnancy

Did you use any medicines when you were pregnant? Here is how you and your health care provider can report what we call an exposure.

Ten principles for stakeholder engagement in the ConcePTION project

The ConcePTION project is building much-needed knowledge for women and health care professionals. To achieve our goal of building an ecosystem for medicine safety in pregnancy and breastfeeding, we need to engage with women, their partners, their doctors, pharmacists, midwives and nurses, the companies that develop medicines and the authorities that approve them and decide what becomes available to patients. Our goal is to work in an open and inclusive way, with the spirit of mutual respect and trust. Here is how we engage with stakeholders in an ethical way.

News

Jul
05
2021
EFEMERIS are looking for a PhD fellow or post-doctoral fellow to join their pharmaco-epidemiology team in the Department of Clinical Pharmacology at the Toulouse School of Medicine, University of Toulouse III. Apply now!  | READ MORE >>
Jun
08
2021
Finding information about medicine safety in pregnancy and breastfeeding is challenging. But the problem extends beyond a mere lack of data. A recent ConcePTION publication reveals that the recommendations for how a drug should be taken by pregnant and breastfeeding women vary a lot between different information sources. Even between the most credible sources and in both information intended for patients and health care professionals. The authors also identify a critical need to harmonise information within and between countries.  | READ MORE >>
Jun
01
2021
Breastfeeding brings many positive effects on the health and wellbeing of both mother and child. But breastfeeding mothers get sick like the rest of us, which means they also need medicines. We believe that each woman should have the right to make decisions about breastfeeding based on information she can trust. We are providing one step in that direction, developing a model for how medicines transfer to milk!  | READ MORE >>

Twitter

A #SystematicReview and meta-analyses on the prevalence of #pregnancy outcomes in #migraine treated patients!

https://doi.org/10.1007/s00415-021-10534-5

#Migraine is the third most common disease in the world, and women are three times more likely to suffer from migraines than men. This poses the question: are the medicines to treat them safe to use during #pregnancy?

https://www.imi-conception.eu/news/news-details?news_id=722

The ConcePTION consortium

The project unites an unprecedented 88 organizations from 22 countries, including the European Medicines Agency, drug manufacturers, academia, public health organizations, and teratology networks to innovate new solutions to a decades-long public health issue.

OUR CONSORTIUM
»

The ConcePTION project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 821520. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.